Transplanting retinal cells to restore vision in patients with macular degeneration
Integration and functionality of retinal organoid transplants
This study is exploring a new way to help people with vision loss from age-related macular degeneration and retinitis pigmentosa by transplanting special clusters of retinal cells to improve their eyesight.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California-Irvine NIH-funded |
| Lab location | 1 site (Irvine, United States) |
| Project ID | NIH-11073068 on NIH RePORTER |
What this research studies
This research investigates the potential of transplanting retinal organoids, which are clusters of retinal cells derived from human embryonic stem cells, to treat vision loss caused by age-related macular degeneration and retinitis pigmentosa. The approach involves combining neural retina sheets containing photoreceptor progenitors with a functional retinal pigment epithelium (RPE) layer to support the transplanted cells. By understanding how these transplants integrate with the host retina, the research aims to improve visual acuity and light responses in patients suffering from severe retinal degeneration.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals suffering from advanced age-related macular degeneration or retinitis pigmentosa who have experienced significant vision loss.
Not a fit: Patients with early-stage macular degeneration or those with other unrelated eye conditions may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that restore vision in patients with advanced macular degeneration.
How similar studies have performed: While the approach of using retinal organoid transplants is innovative, similar strategies have shown promise in preliminary studies, indicating potential for success.
Where this research is happening
Irvine, United States
- University of California-Irvine — Irvine, United States (Active)
Researchers
- Principal investigator: Seiler, Magdalene J — University of California-Irvine
- Study coordinator: Seiler, Magdalene J
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.